Cyclic RGDpeptide The RGDMAA peptide, a specific sequence of amino acids, plays a crucial role in biological processes, particularly in cell adhesionPeptite-2000™ RGD Peptide #5462. This tripeptide motif, Arginyl-Glycyl-Aspartic acid (RGD), is recognized for its ability to bind to integrins, a family of cell surface receptors that mediate cell-to-extracellular matrix interactions. The inclusion of specific amino acids like Alanine (A) in sequences such as RGDMAA can influence the peptide's binding affinity and biological activity, making it a subject of significant interest in biomedical research and drug development.Advanced Biomatrix RGD Peptide Arg-Gly-Asp, 5mg, Sterile Understanding the properties and applications of RGDMAA peptide is essential for researchers and professionals in fields ranging from biomaterials to cancer therapeuticsThe effect of unlocking RGD-motifs in collagen I on pre-osteoblast ....
The core of the RGDMAA peptide's function lies in the RGD sequence itself. This short amino acid triplet is found in numerous extracellular matrix (ECM) proteins, including fibronectin and vitronectin. Its primary role is to serve as a recognition site for integrins. When an RGD sequence is exposed on a protein or peptide, it can bind to specific integrin receptors on cell surfaces作者：J Liu·2020·被引用次数：10—The cyclic RGD (cRGD)peptidehas a particularly high affinity with retinal pigment epithelial cells, where VEGF secretes from. In this study, .... This binding event is critical for a wide array of cellular functions such as cell adhesion, migration, proliferation, and differentiation.Cyclic RGD Peptide Targeting Coated Nano Drug Co- ...
The RGD motif's effectiveness in cell adhesion has led to its widespread use in biomaterialsPeptide Antimicrobial Agents - PMC - NIH. For instance, grafting RGD peptides onto surfaces like hydrogels or implant materials can significantly enhance cell attachment and integration with the host tissue.RGD Peptide (trifluoroacetate salt) This is particularly relevant in tissue engineering and regenerative medicine, where promoting cell-mediated repair and regeneration is paramountRGDSpeptideis a tetrapeptide found on fibronectin, fibrinogen α, and von Willebrand factor, but not vitronectin or collagen.. The RGDMAA peptide, as a specific variant, leverages this fundamental interaction for targeted applications.
While the RGD sequence is broadly recognized by many integrins, modifications to this sequence, such as in RGDMAA, can fine-tune its specificity and efficacy. The inclusion of additional amino acids can alter the peptide's conformation, stability, and affinity for particular integrin subtypes. This tailored approach is vital for developing targeted therapies.
One of the most promising areas for RGDMAA peptide research is cancer targetingThis is a laboratory product for research use only. Not for personal consumption. It will not be effective and is dangerous for personal use. Molecule .... Tumor cells and the associated vasculature often overexpress specific integrinsThis is a laboratory product for research use only. Not for personal consumption. It will not be effective and is dangerous for personal use. Molecule .... RGD-containing peptides can be engineered to selectively bind to these overexpressed integrins, thereby acting as a delivery vehicle for anti-cancer drugs or imaging agents directly to the tumor site.RGD-Peptide cyclo(RGDfC) This targeted approach promises to improve treatment efficacy while minimizing systemic toxicity. For example, cyclic RGD peptides (cRGD), which can offer increased stability and binding affinity, are also being explored for similar anti-cancer applications.
Beyond cancer, RGD peptides, including variants like RGDMAA, are being investigated for their potential in:
* Cardiovascular diseases: Targeting integrins involved in thrombosis or angiogenesis.作者：H Javid·2024·被引用次数：194—RGDpeptidescan be utilized to specifically target cancer cells and the tumor vasculature by engaging with these integrins, improving drug delivery efficiency.
* Ocular diseases: Such as age-related macular degeneration, where specific integrins are implicated.Which of the followingpeptideshas been found to bind or is highly likely to bind an integrin receptor in an in vitro assay? Answer Choices: A.RGDMAAB.
* Wound healing and tissue regeneration: By promoting cell adhesion and migration to damaged areasRGD Peptide|Cas# 114681-65-1.
* Drug delivery: As carriers for various therapeutic agents to specific tissues or cell types.
Despite the significant potential of RGDMAA peptides, several challenges remainPeptide Antimicrobial Agents - PMC - NIH. The stability of short peptides in biological environments can be a concern, leading to rapid degradation by proteases. Strategies to enhance peptide stability, such as cyclization or incorporation into larger molecules or biomaterials, are actively being pursued. Furthermore, understanding the precise integrin-binding profile of specific RGD variants like RGDMAA is crucial for optimizing their therapeutic applications and avoiding off-target effects.
Research into RGD peptides also includes exploring variations in the RGD sequence itself, such as RGDS (Arginyl-Glycyl-Aspartyl-Serine), which has different binding characteristics. The development of novel RGD-containing peptides, including those with modified amino acids or cyclic structures, continues to expand the therapeutic landscape.RGD-targeted ProapoptoticPeptide: Apeptide. CAS Number: 2243207-09-0. Purity: ≥95%. The precise sequence and structure of an RGD peptide, whether it's a simple linear peptide or a more complex cyclic variant, can dramatically influence its interaction with integrins and its overall biological effect.
In conclusion, the RGDMAA peptide, built upon the fundamental RGD cell adhesion motif, represents a powerful tool in modern biomedical researchRGDpeptide(GRGDNP) is an inhibitor of binding of integrins to the extracellular matrixs. RGDpeptide(GRGDNP) induces apoptosis presumably through d.. Its ability to interact with integrins opens doors for targeted therapies in cancer, regenerative medicine, and beyond. As research progresses, we can expect further refinements and innovative applications of this versatile peptide sequence.
Join the newsletter to receive news, updates, new products and freebies in your inbox.